2020
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
Pune
|
|
Delhi
|
|
Bengaluru
|
|
Hyderabad
|
Detailed explanation-1: -Nuvaxovid (Novavax) is approved and available for use as a primary course in people aged 12 years and over. Novavax is approved and available for use as a booster in people aged 18 years and over. The TGA provisionally approved Novavax for use as a primary course in Australia on 20 January 2022.
Detailed explanation-2: -The FDA has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted as a primary series to prevent COVID-19 in individuals 12 years of age and older and as a first booster dose in individuals 18 years of age and older under an EUA.
Detailed explanation-3: -Both COVISHIELD™ (manufactured by Serum Institute of India Pvt Ltd) and COVID-19 Vaccine AstraZeneca (manufactured by AstraZeneca) are ChAdOx1 nCoV- 19 Corona Virus Vaccines (Recombinant).
Detailed explanation-4: -The vaccine is authorized for emergency use to provide: A two-dose primary series to individuals 12 years of age and older.